Works matching AU Il Han Kim


Results: 105
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging.

    Published in:
    PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113587
    By:
    • Kim, Jae Hyun;
    • Choi, Seung Hong;
    • Ryoo, Inseon;
    • Yun, Tae Jin;
    • Kim, Tae Min;
    • Lee, Se-Hoon;
    • Park, Chul-Kee;
    • Kim, Ji-Hoon;
    • Sohn, Chul-Ho;
    • Park, Sung-Hye;
    • Kim, Il Han
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 140, n. 2, p. 445, doi. 10.1007/s11060-018-2972-8
    By:
    • Koo, Taeryool;
    • Lim, Do Hoon;
    • Seol, Ho Jun;
    • Dho, Yun-Sik;
    • Kim, Il Han;
    • Chang, Jong Hee;
    • Lee, Jeongshim;
    • Jung, Tae-Young;
    • Gwak, Ho-Shin;
    • Cho, Kwan Ho;
    • Hong, Chang-Ki;
    • Lee, Ik Jae;
    • Kim, El;
    • Kim, Jin Hee;
    • Hong, Yong-Kil;
    • Jang, Hong Seok;
    • Kim, Chae-Yong;
    • Kim, In Ah;
    • Kim, Sung Hwan;
    • Kim, Young Il
    Publication type:
    Article
    42

    Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

    Published in:
    Journal of Neuro-Oncology, 2018, v. 138, n. 3, p. 667, doi. 10.1007/s11060-018-2839-z
    By:
    • Koo, Taeryool;
    • Lim, Do Hoon;
    • Seol, Ho Jun;
    • Park, Chul-Kee;
    • Kim, Il Han;
    • Chang, Jong Hee;
    • Lee, Jeongshim;
    • Jung, Shin;
    • Gwak, Ho-Shin;
    • Cho, Kwan Ho;
    • Hong, Chang-Ki;
    • Lee, Ik Jae;
    • Kim, El;
    • Kim, Jin Hee;
    • Hong, Yong-Kil;
    • Jang, Hong Seok;
    • Kim, Chae-Yong;
    • Kim, In Ah;
    • Kim, Sung Hwan;
    • Kim, Young Il
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50

    Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 12, p. 1515, doi. 10.1007/s10147-019-01517-8
    By:
    • Choi, Jung Yoon;
    • Kang, Hyoung Jin;
    • Hong, Kyung Taek;
    • Hong, Che Ry;
    • Lee, Yun Jeong;
    • Park, June Dong;
    • Phi, Ji Hoon;
    • Kim, Seung-Ki;
    • Wang, Kyu-Chang;
    • Kim, Il Han;
    • Park, Sung-Hye;
    • Choi, Young Hun;
    • Cheon, Jung-Eun;
    • Park, Kyung Duk;
    • Shin, Hee Young
    Publication type:
    Article